Gail E Jackson

Title: Gail E Jackson: Innovator in Biopharmaceuticals

Introduction

Gail E Jackson is a prominent inventor based in Richmond Hill, Canada. She has made significant contributions to the field of biopharmaceuticals, particularly in the purification of proteins and vaccine development. With a total of 6 patents to her name, her work has had a substantial impact on medical science.

Latest Patents

One of her latest patents focuses on the purification of a pertussis outer membrane protein, known as Pertactin. This innovative process allows for the recovery of Pertactin in a stable biologically pure form, free from detectable adenylate cyclase activity. The method involves processing fermentation broth to selectively remove pertussis toxin and filamentous haemagglutinin. Pertactin is then precipitated using ammonium sulfate and further purified through hydroxyapatite and ion-exchange chromatography, followed by ultrafiltration. This meticulous approach ensures the production of high-quality pertactin for potential vaccine applications.

Career Highlights

Throughout her career, Gail has worked with notable organizations, including Connaught Laboratories Limited. Her expertise in biopharmaceuticals has positioned her as a key figure in the development of effective vaccines and therapeutic proteins.

Collaborations

Gail has collaborated with esteemed colleagues such as Larry U Tan and Raafat Emil Fahim. These partnerships have further enhanced her research and innovation in the field.

Conclusion

Gail E Jackson's contributions to biopharmaceuticals through her innovative patents and collaborations highlight her as a leading inventor in the industry. Her work continues to influence the development of vaccines and therapeutic proteins, showcasing the importance of innovation in healthcare.